MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis
NCT01497223
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class
Conditions
Vulvovaginal Candidiasis
Interventions
DRUG:
MGCD290
Sponsor
MethylGene Inc.